Silent Epidemic: Why 60% of Indian CKD Patients Go Undiagnosed

Recent research highlights a critical gap in CKD detection in India. A pilot study involving nearly 2,000 participants in Andhra Pradesh revealed that chronic kidney disease (CKD) remains a hidden threat. Researchers identified CKD in 57.5% of urban participants and 61.8% of rural participants. However, awareness remains alarmingly low. Specifically, over 98% of urban patients and 83% of rural patients did not know they had the condition. This lack of awareness persists even among high-risk groups with existing comorbidities like diabetes and hypertension.

Urban vs. Rural CKD Disparities

Furthermore, the study identified significant differences between urban and rural populations. While urban patients faced a heavier burden of comorbidities, rural patients often exhibited advanced CKD stages. In rural areas, 12.5% of patients reached stage 4, compared to only 4.4% in urban centers. This discrepancy suggests that environmental factors or unknown causes may drive the epidemic in rural hotspots like Uddanam and A Konduru.

Implementing Early CKD Detection in India

Healthcare providers can address these gaps by adopting innovative tools. Consequently, the study emphasizes the feasibility of using point-of-care tests and digital health solutions in primary health centers. These tools allow non-specialized workers to collect vital data. Moreover, early CKD detection in India through such platforms can lead to timely nephrology referrals. This approach is not only clinical but also cost-effective for patients paying out-of-pocket.

Overcoming Economic and Policy Barriers

Significant barriers to care still remain. Currently, India’s national NCD program focuses primarily on hypertension and diabetes, excluding CKD from preventive care. Since only 15% of the population has health insurance, routine laboratory tests are often unaffordable. Therefore, integrating kidney care into routine primary health practice is essential. By expanding screening programs, the healthcare system can reduce complication rates and improve long-term patient outcomes significantly. Professionals focused on chronic disease management, especially those dealing with metabolic issues, can benefit from advanced training in areas like diabetes mellitus management to better address CKD comorbidities.

Frequently Asked Questions

Q1: Why is awareness of CKD so low in India?

Awareness is low because CKD is often asymptomatic in its early stages. Additionally, limited access to routine screening and high out-of-pocket costs prevent many high-risk individuals from receiving a timely diagnosis.

Q2: How does the rural CKD profile differ from the urban one?

Rural patients frequently present with more advanced disease despite having fewer traditional risk factors like diabetes. This suggests environmental triggers or “CKD of unknown origin” in specific geographic hotspots like Uddanam. For clinicians managing these chronic conditions, further specialization is invaluable; consider exploring our offerings in Nephrology Speciality Courses.

Q3: What are point-of-care tests for CKD?

Point-of-care tests are rapid diagnostic tools used at the site of patient care, such as local clinics. They allow for immediate screening of albuminuria and creatinine levels, facilitating faster clinical decisions.

References

Silent epidemic: 60% CKD patients unaware of their condition, finds study – ETHealthworld
Chinta, R. K., Shri, V., Milojkovic, B., et al. (2025). Point-of-Care Testing and Integrated Digital Health Technology for CKD Screening in High-Risk Populations of India. Kidney International Reports.
M, S. R. (2024). 60% of diabetes patients have some form of kidney ailment, says HelloKidney.ai pilot project. The Hindu.

Disclaimer: This article was automatically generated from publicly available sources and is provided for informational and educational purposes only. OC Academy does not exercise editorial control or claim authorship over this content. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider and refer to current local and national clinical guidelines.